Search Results - "Veit, Stefanie"

Phase II Trial of a Trimodality Regimen for Stage III Non–Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Center Study by FRIEDEL, Godehard, BUDACH, Wilfried, VEIT, Stefanie, KIMMICH, Martin, BAMBERG, Michael, KOHLHAEUFL, Martin, STEGER, Volker, HEHR, Thomas, DIPPON, Juergen, SPENGLER, Werner, ESCHMANN, Susanne Martina, PFANNENBERG, Christina, AL-KAMASH, Fawaz, WALLES, Thorsten, AEBERT, Hermann, KYRISS, Thomas

“…PURPOSE We started a phase II trial of induction chemotherapy and concurrent hyperfractionated chemoradiotherapy followed by either surgery or boost…”
Get full text

Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival by Steger, Volker, MD, Walles, Thorsten, MD, Kosan, Bora, MD, Walker, Tobias, MD, Kyriss, Thomas, MD, Veit, Stefanie, MD, Dippon, Jürgen, PhD, Friedel, Godehard, MD

“…Background Surgery alone for stage III non–small cell lung cancer provides a 5-year survival of 20% and competes with multimodal treatments. In 1999, a…”
Get full text

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer by Friedel, Godehard, MD, FETCS, Kuipers, Thomas, MD, Dippon, Jürgen, PhD, Al-Kammash, Fawaz, MD, Walles, Thorsten, MD, Kyriss, Thomas, MD, Veit, Stefanie, MD, Greulich, Michael, MD, Steger, Volker, MD

“…Background Despite available recommendations, therapeutic procedures of locally recurrent breast cancer are very different. This retrospective study presents…”
Get full text

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE) by Eberhardt, Wilfried Ernst Erich, Pöttgen, Christoph, Gauler, Thomas Christoph, Friedel, Godehard, Veit, Stefanie, Heinrich, Vanessa, Welter, Stefan, Budach, Wilfried, Spengler, Werner, Kimmich, Martin, Fischer, Berthold, Schmidberger, Heinz, De Ruysscher, Dirk, Belka, Claus, Cordes, Sebastian, Hepp, Rodrigo, Lütke-Brintrup, Diana, Lehmann, Nils, Schuler, Martin, Jöckel, Karl-Heinz, Stamatis, Georgios, Stuschke, Martin

“…Concurrent chemoradiotherapy with or without surgery are options for stage IIIA(N2) non-small-cell lung cancer. Our previous phase II study had shown the…”
Get full text

Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? by Steger, Volker, Spengler, Werner, Hetzel, Jürgen, Veit, Stefanie, Walker, Tobias, Mustafi, Migdat, Friedel, Godehard, Walles, Thorsten

“…OBJECTIVES Lung cancer is the leading cause of death in cancer statistics throughout developed countries. While single surgical approach provides best results…”
Get full text

Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability by Hampel, Martina, Dally, Iris, Walles, Thorsten, Steger, Volker, Veit, Stefanie, Kyriss, Thomas, Friedel, Godehard

“…Objective: In the treatment of advanced stages of lung cancer, increasingly more multimodality approaches applying radiotherapy and/or chemotherapy in a…”
Get full text

Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE) by Eberhardt, Wilfried Ernst Erich, Gauler, Thomas Christoph, Pöttgen, Christoph, Friedel, Godehard, Veit, Stefanie, Heinrich, Vanessa, Welter, Stefan, Spengler, Werner, Kimmich, Martin, Fischer, Berthold, Schmidberger, Heinz, Gkika, Eleni, Cordes, Sebastian, Hepp, Rodrigo, Luetke-Brintrup, Diana, Lehmann, Nils, Schuler, Martin H., Jöckel, Karl-Heinz, Stamatis, Georgios, Stuschke, Martin

“…Abstract only…”
Get full text

Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC by Steger, Volker, Veit, Stefanie, Walker, Tobias, Friedel, Godehard, Lehrach, Karoline, Mustafi, Migdat, Walles, Thorsten

“…For stage III, NSCLC neoadjuvant protocols have been intensified up to full dose protocols but up till now the effect of more intensive protocols in a trimodal…”
Get more information

Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk? by Steger, Volker, Walker, Tobias, Mustafi, Migdat, Lehrach, Karoline, Kyriss, Thomas, Veit, Stefanie, Friedel, Godehard, Walles, Thorsten

“…OBJECTIVES Persistent mediastinal lymph node metastasis after neoadjuvant therapy is a significant negative indicator for survival. Even though there is still…”
Get full text

Long-term efficiency of endoscopic thoracic sympathicotomy: survey 10 years after surgery by Walles, Thorsten, Somuncuoglu, Geesche, Steger, Volker, Veit, Stefanie, Friedel, Godehard

“…Department of Thoracic Surgery, Schillerhoehe Hospital, Solitudestrasse 18, D-70839 Gerlingen, Germany *Corresponding author. Tel.: +49-7156-203-2241; fax:…”
Get full text

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer. Commentary by FRIEDEL, Godehard, KUIPERS, Thomas, COLSON, Yolonda L, DIPPON, Jiirgen, AL-KAMMASH, Fawaz, WALLES, Thorsten, KYRISS, Thomas, VEIT, Stefanie, GREULICH, Michael, STEGER, Volker, CAMP, Phillip L

Get full text

Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability. Discussion by HAMPEL, Martina, DALLY, Iris, WALLES, Thorsten, STEGER, Volker, VEIT, Stefanie, KYRISS, Thomas, FRIEDEL, Godehard, LESCHBER, G, STOCKHAUSEN, D

Get full text

Carcinoid lung tumors: long-term results from 111 resections by Kyriss, Thomas, Maier, Sibylle, Veit, Stefanie, Fritz, Peter, Toomes, Heikki, Friedel, Godehard

“…Carcinoids are rare neuroendocrine tumors of the bronchial system. Only recently, the histological classification was standardized, and there are varying…”
Get full text

Full-thickness chest wall resection for locally recurrent breast cancer by Friedel, Godehard, Kuipers, Thomas, Engel, Corinna, Schopf, Christine, Veit, Stefanie, Zoller, Jutta, Kyriss, Thomas, Greulich, Michael, Toomes, Heikki

“…In spite of available recommendations, therapeutic procedures of locally recurrent breast cancer are very different. In a retrospective study, the…”
Get full text